Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Other Operating Expenses (2018 - 2025)

Dna X's Other Operating Expenses history spans 8 years, with the latest figure at -$11.9 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at -$11.9 million for Q4 2025, up 54.75% from a year ago — trailing twelve months through Dec 2025 was -$2.7 million (up 80.87% YoY), and the annual figure for FY2024 was -$14.7 million, down 268.21%.
  • Other Operating Expenses for Q4 2025 was -$11.9 million at Dna X, down from $2.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $6.4 million in Q2 2024 to a low of -$26.2 million in Q4 2024.
  • The 5-year median for Other Operating Expenses is $2.5 million (2024), against an average of $736900.0.
  • Peak annual rise in Other Operating Expenses hit 252.27% in 2024, while the deepest fall reached 959.0% in 2024.
  • Year by year, Other Operating Expenses stood at $4.7 million in 2021, then tumbled by 67.68% to $1.5 million in 2022, then surged by 100.72% to $3.1 million in 2023, then crashed by 959.0% to -$26.2 million in 2024, then soared by 54.75% to -$11.9 million in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$11.9 million, $2.5 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.